Accordingly, LCN2 regulates the gut microbiota composition and intestinal permeability, i.e., factors that may lead to systemic inflammation, insulin resistance, metabolic syndrome, and related characteristics (217). The gene discussed is LCN2; the disease is Insulin resistance.